NIAAA R13 ISBRA Travel Support Opportunity
RSA/ISBRA Joint Scientific Meeting
June 19 - 23, 2021 San Antonio, TX, USA

We are pleased to announce that the National Institute on Alcohol Abuse and Alcoholism (NIAAA) has provided conference grant funds for the 20th ISBRA Congress to be held in San Antonio, TX, USA from June 19-23, 2021. The ISBRA Congress will be held in conjunction with the 44th Annual RSA Scientific Meeting. Information on the RSA/ISBRA 2020 Joint Scientific Meeting is available here.

Through a competitive process, this conference grant will provide partial travel support for selected ISBRA members to present at the Congress. Priority will be given to junior level alcohol researchers (≤8 years past their doctorate degree) and scientists from underrepresented demographic groups or countries. To be considered for support, the applicant must be an active member of ISBRA and be up-to-date on their dues. Individuals who are not already ISBRA members are encouraged to apply online for membership separately by January 2, 2021 at at the ISBRA membership page. Any ISBRA membership questions should be directed to

The online application for travel support is below and must be completed by January 11, 2021 to receive priority consideration. The applications will be reviewed and applicants will be informed as to whether or not they have been selected to receive any travel assistance. If selected, the amount of travel assistance and allowable expenses for reimbursement will be delineated in the notification email.

All reimbursements for those selected for support from this NIAAA R13 grant will occur after the Congress.

Edward Riley, Ph.D. and Jennifer Thomas, Ph.D.
Principal Investigators of the NIAAA R13 ISBRA Grant

Funding for this conference was made possible (in part) by 5R13AA022578-07 from the National Institute on Alcohol Abuse and Alcoholism (NIAAA). The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.